Propranolol Titration for Secondary Prophylaxis in Decompensated Cirrhosis

Initial Dosing Strategy

• The American College of Cardiology recommends starting propranolol at 20-40 mg twice daily and titrating cautiously to a maximum of 160 mg daily, targeting a heart rate of 55-60 bpm while maintaining systolic blood pressure ≥90 mmHg 1, 2
• Long-acting formulations (80-160 mg daily) can be used to improve compliance once stable dosing is established, as suggested by the European Association for the Study of the Liver 3, 1

Titration Protocol

• Increase dose every 2-3 days based on heart rate response and tolerability, with a target heart rate of 55-60 beats per minute or 25% reduction from baseline, as recommended by the American Association for the Study of Liver Diseases 2
• The maximum dose in decompensated cirrhosis with ascites is 160 mg daily, significantly lower than the 320 mg allowed in compensated patients, according to the American College of Gastroenterology 1, 2

Monitoring Requirements in Decompensated Disease

• Blood pressure should be monitored at each visit, maintaining systolic BP ≥90 mmHg, as recommended by the European Society of Gastrointestinal Endoscopy 2
• Serum creatinine and serum sodium should be monitored, with dose reduction or discontinuation if creatinine exceeds 1.5 mg/dL or sodium falls below 130 mmol/L, as suggested by the American Association for the Study of Liver Diseases 2

Special Considerations for Refractory Ascites

• In refractory ascites, consider limiting propranolol to 80 mg daily for safety, as recommended by the American College of Cardiology 1, 4
• Recent evidence suggests low-dose propranolol (80 mg/day) in spontaneous bacterial peritonitis patients is associated with improved survival, according to the European Association for the Study of the Liver 2

When to Reduce or Discontinue

• Dose reduction is preferred over complete discontinuation when possible, as abrupt cessation increases variceal bleeding risk and mortality, as recommended by the American Association for the Study of Liver Diseases 2, 4

Alternative Strategies

• If propranolol cannot be used, first-line alternative is endoscopic variceal ligation, as recommended by the American Society for Gastrointestinal Endoscopy 3, 1
• Second-line alternative is isosorbide mononitrate 20 mg twice daily, though less effective, according to the European Association for the Study of the Liver 3, 1

Therapeutic Goals

• Target endpoints include hepatic venous pressure gradient (HVPG) <12 mmHg or ≥20% reduction from baseline, as recommended by the American Association for the Study of Liver Diseases 3, 1
• Prevention of rebleeding while avoiding hemodynamic compromise is a key principle, as suggested by the American College of Cardiology 2